Graves Disease
TSH, Free T4, Free T3, and TSH Receptor Antibodies to help assess Graves' disease.
TSI is an antibody that may signal Graves' disease, an autoimmune condition affecting the thyroid. Monitoring TSI can be a valuable part of understanding your overall thyroid health and metabolic wellbeing. Your healthcare provider can offer personalised guidance based on your results.
Doctor's Assessment Included
No established reference range
There is no generally accepted reference value for TSI (TSH-receptor antibodies). The NVKC states that no general normal values are available and that reference values depend on the assay used. The Dutch thyroid guideline states that an absolute cut-off cannot be formulated, because the available assays are not standardised against one another; it therefore uses a threshold of three times the performing laboratory's own upper limit. For TSI it is not only the cut-off that differs by method but the unit itself: laboratories report this test in international units per litre, as a percentage of stimulation relative to a reference, or simply as positive or negative. Your result is therefore always assessed against both the unit and the cut-off of the laboratory that ran the test.
Reference ranges may vary between laboratories. When you order a test, a BIG-registered doctor assesses your personal results in context. For treatment decisions, discuss your results with your GP.
This test measures thyroid-stimulating immunoglobulin antibodies in your blood. These antibodies may bind to TSH receptors on the thyroid gland, potentially stimulating excess thyroid hormone production. TSI is considered a key diagnostic indicator that healthcare providers use when evaluating suspected Graves' disease.
Understanding your TSI levels may help you and your healthcare provider take a proactive approach to thyroid health. Early detection of Graves' disease antibodies can support timely intervention and may help prevent complications that could affect your daily quality of life.
Healthcare providers may recommend TSI testing when hyperthyroidism is suspected, particularly if symptoms such as unexplained weight loss, rapid heartbeat, or eye changes are present. It may also be used to monitor Graves' disease treatment progress or during pregnancy when thyroid antibodies could affect the baby.
While lifestyle changes alone may not directly lower TSI levels, some people find that stress management techniques, adequate sleep, and a balanced diet may support overall thyroid health. Avoiding excessive iodine intake is sometimes recommended. Always follow your healthcare provider's guidance regarding treatment and lifestyle modifications.
These panels measure values from the same category as this marker.
TSH, Free T4, Free T3, and TSH Receptor Antibodies to help assess Graves' disease.
Broad health panel: CBC, thyroid, vitamins, lipids, liver, kidney, and HbA1c.
Investigate some common causes of fatigue: CBC, thyroid, iron, vitamins, glucose, and HbA1c.
Thyroid panel: TSH, Free T4, and Free T3.
TSI (Thyroid Stimulating Immunoglobulin)
€81,-